Recent Clinical Advances in Reducing Risk for Dyslipidemia

Recent Clinical Advances in Reducing Risk for...

Suivant

A Natural Winner: Plant-Based Diets and Statins vs Dyslipidemia Risk

In this episode, Dr Laurence Sperling talks with Dr Kim Williams about preventive cardiology nutrition intervention as a key co-therapy for tackling dyslipidemia. Relevant disclosures can be found with the episode show notes on Medscape.com ( https://www.medscape.com/viewarticle/9 ...  Afficher plus

Top 10 Take-home Messages From the 2018 ACC/AHA Cholesterol Guidelines

Drs Laurence Sperling and Neil Stone put key messages from the 2018 cholesterol guidelines into a clear clinical context. Relevant disclosures can be found with the episode show notes on Medscape.com ( https://www.medscape.com/viewarticle/958747). The topics and discussions are pl ...  Afficher plus

Épisodes Recommandés

Clopidogrel Versus Aspirin For Long-term Maintenance Monotherapy In Patients With High Ischemic Risk After PCI
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

The SMART-CHOICE 3 trial demonstrated that clopidogrel monotherapy is more effective than aspirin monotherapy in reducing the risk of major adverse cardiac and cerebrovascular events in high-risk patients who completed standard dual antiplatelet therapy (DAPT) following percutane ...  Afficher plus

#334 - Cardiovascular disease, the number one killer: development, biomarkers, apoB, cholesterol, brain health, and more | Tom Dayspring, M.D.
The Peter Attia Drive

View the Show Notes Page for This Episode

<a href= "https://peterattiamd.com/subscribe/ ...

  Afficher plus

Reframing Cardiovascular Care | JACC This Week
JACC This Week

In this episode, Dr. Harlan Krumholz introduces the September 16, 2025 issue of JACC, which features studies that challenge conventional clinical thinking, including a detailed ECMO physiology study showing that higher ECMO flow does not uniformly raise pulmonary capillary wedge ...  Afficher plus

Review of the Primary Angioplasty in Myocardial Infarction Study Group trial
Cardiology Trials

N Engl J Med 1993;328:673-679Background: Previous trials established that thrombolysis improves mortality in patients with acute myocardial infarction, as seen in the GISSI-1 and ISIS-2 trials. However, thrombolysis has limitations, including an increased risk of bleeding and the ...  Afficher plus